Literature DB >> 21181106

[Complementary therapy in palliative medicine].

J Hübner1, C Stoll.   

Abstract

Even in the palliative context complementary therapy has a high value for patients and their relatives. In contrast to the methods of conventional medicine naturopathy as a holistic system has positive meanings for patients and their family. Complementary medicine in the palliative setting can be used as a supportive therapy in carefully selected cases. Doctors and patients should be careful regarding effect and side effects and should make sure that supportive therapy is given adequately and in effective doses. Complementary therapy should not be used in order to avoid the question of life and death. An adequate approach to the topic is mandatory, which acknowledges the needs of patients but also looks for their safety. Patients following alternative therapies sometimes neglect helpful therapeutic options. Carefully providing information on these therapies is mandatory. Physicians should avoid losing patients' confidence in their competence and attention in their final course of disease. Also in palliative medicine a sensitive approach to the topic of complementary medicine is mandatory, which accounts for the eligible wishes of patients and their relatives but puts the patients safety first.

Entities:  

Mesh:

Year:  2011        PMID: 21181106     DOI: 10.1007/s00108-010-2691-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  20 in total

Review 1.  A critical review of complementary therapies for cancer-related fatigue.

Authors:  Amit Sood; Debra L Barton; Brent A Bauer; Charles L Loprinzi
Journal:  Integr Cancer Ther       Date:  2007-03       Impact factor: 3.279

Review 2.  Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia.

Authors:  A Dewey; C Baughan; T Dean; B Higgins; I Johnson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 3.  N-3 fatty acids, cancer and cachexia: a systematic review of the literature.

Authors:  Ramón Colomer; José M Moreno-Nogueira; Pedro P García-Luna; Pilar García-Peris; Abelardo García-de-Lorenzo; Antonio Zarazaga; Luis Quecedo; Juan del Llano; Luis Usán; César Casimiro
Journal:  Br J Nutr       Date:  2007-05       Impact factor: 3.718

4.  Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.

Authors:  Florian Strasser; Diana Luftner; Kurt Possinger; Gernot Ernst; Thomas Ruhstaller; Winfried Meissner; You-Dschun Ko; Martin Schnelle; Marcus Reif; Thomas Cerny
Journal:  J Clin Oncol       Date:  2006-07-20       Impact factor: 44.544

Review 5.  Massage therapy for cancer palliation and supportive care: a systematic review of randomised clinical trials.

Authors:  E Ernst
Journal:  Support Care Cancer       Date:  2009-01-13       Impact factor: 3.603

6.  The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial.

Authors:  M Motallebnejad; S Akram; A Moghadamnia; Z Moulana; S Omidi
Journal:  J Contemp Dent Pract       Date:  2008-03-01

7.  Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

Authors:  E T Creagan; C G Moertel; J R O'Fallon; A J Schutt; M J O'Connell; J Rubin; S Frytak
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

8.  Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.

Authors:  L J Hoffer; M Levine; S Assouline; D Melnychuk; S J Padayatty; K Rosadiuk; C Rousseau; L Robitaille; W H Miller
Journal:  Ann Oncol       Date:  2008-06-09       Impact factor: 32.976

9.  Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.

Authors:  E Cameron; L Pauling
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

10.  Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting.

Authors:  Suzanna M Zick; Mack T Ruffin; Julia Lee; Daniel P Normolle; Rivka Siden; Sara Alrawi; Dean E Brenner
Journal:  Support Care Cancer       Date:  2008-11-13       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.